VACCINATIONS News & Analysis

Households and businesses are in good shape and vaccine-driven herd immunity will propel growth, writes Preston Caldwell.

Covid will create a $52bn vaccine and treatment market and usher in immunity by 2023, writes Morningstar's Karen Andersen.

The plasma giant remains overvalued, according to Morningstar.

American Century Investments' low-turnover strategy invests in companies developing vaccines, treatments for neuro-cognitive diseases and innovations...

Opportunistic investors could consider several companies with infectious disease and vaccine expertise.

Australia's largest funeral provider InvoCare is trading more than 8 per cent higher despite a dip in revenue linked to a milder winter and effective...